Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 21 days ago Drug news

Phase III ENGAGE AF-TIMI 48 trial shows Lixiana (edoxaban) provides benefits in patients with different stroke risk.-Daiichi Sankyo.

Daiichi Sankyo announced new sub-analysis data, demonstrating that Lixiana (edoxaban) provides comparable efficacy and greater safety compared to warfarin, across...

Added 22 days ago Drug news

Real world data from among non-valvular atrial fibrillation (NVAF) patients shows Eliquis (apixaban) reduces risk of stroke.-BMS/Pfizer.

Bristol-Myers Squibb and Pfizer announced results from an analysis of real-world data showing that among non-valvular atrial fibrillation (NVAF) patients,...

Added 3 months ago Drug news

FDA approves Sentinel Cerebral Protection System to protect against risk of stroke during TAVR procedures.- Claret Medical

Claret Medical announced that it has received regulatory clearance from the FDA for the Sentinel Cerebral Protection System (CPS), via...

Search all news articles for Acute cerebrovascular disease

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Oral Anticoagulation Reversal

Experts discuss the use of non-vitamin K oral anticoagulants in the treatment and prevention of stroke, deep vein thrombosis and pulmonary embolism in atrial fibrillation patients.

Visit Oral Anticoagulation Reversal


Essential screening, diagnosis and best strategies to manage bedwetting.

+ 3 more

Visit Bedwetting


Guideline for reversal of antithrombotics in intracranial hemorrhage.

The use of antithrombotic agents, including anticoagulants, antiplatelet agents, and thrombolytics has increased over the last decade and is expected to continue to rise.

Added 6 months ago

European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke

Hyperthermia is a frequent complication in up to 50% of patients with acute ischemic stroke, and it was shown to...

Added 2 years ago

European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage

These guidelines inform the management of Intracerebral hemorrhage (ICH) based on evidence for the effects of treatments in randomized controlled...

Added 2 years ago

Search all guidelines for Acute cerebrovascular disease

Journal articles

Medical treatment for spontaneous anticoagulation-related intracerebral hemorrhage in the Netherlands

Spontaneous anticoagulation-related intracerebral hemorrhage accounts for up to a quarter of spontaneous intracerebral hemorrhage cases and is associated with higher hematoma volume and a worse outcome.

Added 2 months ago

Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical Guide.

Edoxaban is the fourth non-vitamin K antagonist oral anticoagulant now available for clinical use in the prevention of stroke/systemic embolism in atrial fibrillation (AF) and in the treatment of venous thromboembolism (VTE) ...

Added 3 months ago

Edoxaban: A direct oral anticoagulant.

Purpose: The pharmacology, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, and place in therapy of edoxaban for prevention of stroke in patients with nonvalvular atrial fibrillation (AF) and ...

Added 3 months ago

Search all journal articles for Acute cerebrovascular disease


Stroke: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee
Search all CME for Acute cerebrovascular disease